BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed TLTFF catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:dc47249cc004481b80b7@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:TLTFF P2 readout (est.): Intravesical Photodynamic Therapy ("PDT") 
 in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC"
 ) Patients
DESCRIPTION:Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/I
 ntolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients\nNCT039451
 62 | PHASE2 | RECRUITING | sponsor: Theralase® Technologies Inc.\nPrimary
  completion date (ESTIMATED)\; top-line results usually follow later.\nDat
 e precision: month (shown on the first day)\nTicker TLTFF (confidence 0.6)
 \nSource: https://clinicaltrials.gov/study/NCT03945162\nScheduling/referen
 ce data from public records\; dates can move. Not investment\, legal or me
 dical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT03945162
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
